Page 1444 - Williams Hematology ( PDFDrive )

1418 Part X: Malignant Myeloid Diseases Chapter 88: Acute Myelogenous Leukemia 1419

228. Hunter TB, Bjelland JC: Gastrointestinal complications of leukemia and its treatment. 264. Andrieu V, Radford-Weill I, Troussand X, et al: Molecular detection of t(8;21)/AML1-
AJR Am J Roentgenol 142:513, 1984. ETO in AML M1/M2: Correlation with cytogenetics, morphology and immunophe-
229. Duffy JH, Driscoll EJ: Oral manifestations of leukemia. Oral Surg Oral Med Oral Pathol notype. Br J Haematol 92:855, 1996.
11:484, 1958. 265. Rege K, Swansbury GJ, Atra AA, et al: Disease features in acute myeloid leukemia with
230. Ahsan N, Schen-Chih, JS, John DD: Acute ileotyphlitis as presenting manifestation of t(8;21)(q22;q22). Influence of age, secondary karyotypic abnormalities, CD19 status,
acute myelogenous leukemia. Am J Clin Pathol 89:407, 1988. and extramedullary leukemia. Leuk Lymphoma 40:67, 2000.
231. Rodgers B, Seibert JJ: Unusual combination of an appendicolith in a leukemic patient 266. Nguyen S, Leblanc T, Fenaux P, et al: A white blood cell index as the main prognos-
with typhlitis-ultrasound diagnosis. J Clin Ultrasound 18:141, 1990. tic factor in t(8;21) acute myeloid leukemia (AML): A survey of 161 cases from the
232. Abramson SJ, Berdon WE, Baker DH: Childhood typhlitis: Its increasing association French AML intergroup. Blood 99:3517, 2002.
with acute myelogenous leukemia. Radiology 146:61, 1983. 267. Rowe JM: Clinical and laboratory features of the myeloid and lymphoid leukemias.
233. Bagnoli P, Castagna L, Cozzaglio L, et al: Neutropenic enterocolitis: Is there a right Am J Med Technol 49:103, 1983.
timing for surgery? Assessment of a clinical case. Tumori 93:608, 2007. 268. Woodcock BE, Cooper PC, Brown PR, et al: The platelet defect in acute myeloid leu-
234. Roy J, Vercellotti G, Fenderson M, et al: Isolated relapse of acute myelogenous leuke- kemia. J Clin Pathol 37:1339, 1984.
mia presenting as a gastric ulcer. Am J Hematol 37:270, 1991. 269. Hofmann WK, Stauch M, Höffken K: Impaired granulocytic function in patients
235. Thompson BC, Feczko PJ, Mezwa DG: Dysphagia caused by acute leukemia infiltra- with acute leukaemia: Only partial normalization after successful remission-inducing
tion of the esophagus. AJR Am J Roentgenol 155:654, 1990. treatment. J Clin Res Clin Oncol 124:113, 1998.
236. Ti M, Villafuerte R, Chase PH, Dosik H: Acute leukemia presenting as laryngeal 270. Suda T, Onai T, Maekawa T: Studies on abnormal polymorphonuclear neutrophils in
obstruction. Cancer 34:427, 1974. acute myelogenous leukemia. Am J Hematol 15:45, 1983.
237. Bodey GP, Powell RD, Hersh EM, et al: Pulmonary complications of acute leukemia. 270a. Glick AD, Paniker K, Flexner JM, et al: Acute leukemia of adults: Ultrastructural,
Cancer 19:781, 1966. cytochemical, and histological observations in 100 cases. Am J Pathol 73:459, 1980.
238. Maile CW, Moore AV, Ulreich S, Putnam CE: Chest radiographic pathologic correla- 271. Lichtman MA: Does a diagnosis of myelogenous leukemia require 20% marrow mye-
tion in adult leukemia patients. Invest Radiol 18:495, 1983. loblasts, and does <5% marrow myeloblasts represent a remission? The history and
239. Armstrong P, Dyer R, Alford BA, O’Hara M: Leukemic pulmonary infiltrates. Rapid ambiguity of arbitrary diagnostic boundaries in the understanding of myelodysplasia.
development mimicking pulmonary edema. AJR Am J Roentgenol 135:373, 1980. Oncologist 18:973, 2013.
240. Wu KK, Burns CP: Leukemic pleural infiltrates during bone marrow remission of 272. Bacher U, Kern W, Alpermann T, et al: Prognosis in patients with MDS or AML and
acute myelocytic leukemia. Cancer 33:1179, 1974. bone marrow blasts between 10% and 30% is not associated with blast counts but
241. Roberts WC, Bodey GP, Wertlake PT: The heart in acute leukemia. A study of 420 depends on cytogenetic and molecular genetic characteristics. Leukemia 25:1361,
autopsy cases. Am J Cardiol 21:388, 1968. 2011.
242. Lisker SA, Finkelstein D, Brody JI, Beizer LH: Myocardial infarction in acute leuke- 273. San Miguel JF, Conzalez M, Canizo MC, et al: TdT activity in acute myeloid leukemias
mia. Arch Intern Med 119:332, 1967. defined by monoclonal antibodies. Am J Hematol 23:9, 1986.
243. Norris NH, Weiner J: The renal lesions in leukemia. Am J Med Sci 241:512, 1961. 274. Kaplan SS, Penchansky L, Krause JR, et al: Simultaneous evaluation of terminal deox-
244. Uno Y: Histopathological study of leukemic cell infiltration in the kidney. Med J Osaka ynucleotidyl transferase and myeloperoxidase in acute leukemias using an immuno-
Univ 18:185, 1967. cytochemical method. Am J Clin Pathol 87:732, 1987.
245. Russo A, Basquez E, Russo G, Schilvio G: Testicular relapse in acute myelogenous 275. Kahl C, Florschü tz A, Müller G, et al: Prognostic significance of dysplastic features
leukemia after 3 1/2 years of complete remission. Acta Haematol 65:131, 1981. of hematopoiesis in patients with de novo acute myelogenous leukemia. Ann Hematol
246. Quien ET, Wallach B, Sandhaus L, et al: Primary extramedullary leukemia of the pros- 75:91, 1997.
tate. Am J Hematol 53:267, 1996. 276. Manoharan A, Horsley R, Pitney WR: The reticulin content of bone marrow in acute
247. Vanden Broecke R, Van Droogenbroek J, Dhont M: Vulvovaginal manifestations of leukemia in adults. Br J Haematol 43:185, 1979.
acute myeloblastic leukemia. Obstet Gynecol 88:735, 1996. 277. Moehler TM, Ho AD, Goldschmidt H, Barlogie B: Angiogenesis in hematologic
248. Marsh WL, Byland DJ, Heath VC, Anderson MJ: Osteoarticular and pulmonary man- malignancies. Crit Rev Oncol Hematol 45:227, 2003.
ifestations of acute leukemia. Cancer 57:385, 1986. 278. Albitar M: Angiogenesis in acute myeloid leukemia and myelodysplastic syndrome.
249. Weinberger A, Schumacher R, Schimmer BM, et al: Arthritis in acute leukemia. Arch Acta Haematol 106:170, 2001.
Intern Med 141:1183, 1981. 279. Ghannadan M, Wimazal F, Simonitsch I, et al: Immunohistochemical detection of
250. Pavlovsky S, Eppinger-Helft M, Murill FS: Factors that influence the appearance of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation
central nervous system leukemia. Blood 42:935, 1973. between VEGF expression and the FAB category. Am J Clin Pathol 119:663, 2003.
251. Meyer RJ, Ferreira PP, Cuttner J, et al: Central nervous system involvement at presen- 280. Chi Y, Lindgren V, Quigley S, Gaitonde S: Acute myelogenous leukemia with t(6;9)
tation in acute granulocytic leukemia. Am J Med 68:691, 1980. (p23;q34) and marrow basophilia: An overview. Arch Pathol Lab Med 132:1835, 2008.
252. Castagnola C, Morra E, Bernasconi P, et al: Acute myeloid leukemia and diabetes 281. Seiter K: Diagnosis and management of core-binding factor leukemias. Curr Hematol
insipidus: Results in five patients. Acta Haematol 93:1, 1995. Rep 2:78, 2003.
253. Holmes R, Keating MJ, Cork A, et al: A unique pattern of central nervous system leu- 282. Mrózek K, Heinonen K, De la Chapelle A, Bloomfield C: Clinical significance of cyto-
kemia in acute myelomonocytic leukemia associated with inv (16) (p13;q32). Blood genetics in acute myeloid leukemia. Semin Oncol 24:17, 1997.
65:1071, 1985. 283. Schoch C, Haferlach T, Haase D, et al: Patients with de novo acute myeloid leukaemia
254. Glass JP, VanTassel P, Keating MJ, et al: Central nervous system complications of a and complex karyotype aberrations show a poor prognosis despite intensive treat-
newly recognized subtype of leukemia: AMML with a pencentric inversion of chro- ment: A study of 90 patients. Br J Haematol 112:118, 2001.
mosome 16. Neurology 38:639, 1987. 284. Weltermann A, Fonatsch C, Haas OA, et al: Impact of cytogenetics on the prognosis
255. Neiman RS, Barcos M, Berard C, et al: Granulocytic sarcoma: A clinicopathologic of adults with de novo AML in first relapse. Leukemia 18:293, 2004.
study of 61 biopsied cases. Cancer 48:426, 1981. 285. Martinez-Climent JA, Lane NJ, Rubin CM, et al: Clinical and prognostic significance
256. Byrd JC, Edenfield WJ, Shields DJ, Dawson NA: Extramedullary myeloid cell of chromosomal abnormalities in childhood acute myeloid leukemia de novo. Leuke-
tumors in acute nonlymphocytic leukemia. A clinical review. J Clin Oncol 13:1800, mia 9:95, 1995.
1995. 286. Pedersen-Bjergaard J, Philip P: Chromosome characteristics of therapy-related acute
257. Menasce LP, Banerjee SS, Becket E, Harris M: Extramedullary myeloid tumor (gran- nonlymphocytic leukemia and preleukemia: Possible implications for pathogenesis of
ulocytic sarcoma) is often misdiagnosed. A study of 26 cases. Histopathology 34:391, the disease. Leuk Res 11:315, 1987.
1999. 287. Zaccarea A, Alimena G, Baccarani M, et al: Cytogenetic analyses in 89 patients with
258. Audouin J, Comperat E, Le Tourneau A, et al: Myeloid sarcoma: Clinical and morpho- secondary hematologic disorders: Results of a cooperative study. Cancer Genet Cyto-
logic criteria useful for diagnosis. Int J Surg Pathol 11:271, 2003. genet 26:65, 1987.
259. Hernandez JA, Navarro JT, Rozman M, et al: Primary myeloid sarcoma of the gyne- 288. Schoch C, Kern W, Krawitz P, et al: Dependence of age-specific incidence of acute
cologic tract: A report of two cases progressing to acute leukemia. Leuk Lymphoma myeloid leukemia on karyotype. Blood 98:3500, 2002.
43:2151, 2002. 289. Byrd JC, Lawrence D, Arthur DC, et al: Patients with isolated trisomy 8 in acute
260. Tsimberidou AM, Kantarjian HM, Estey E, et al: Outcome in patients with nonleuke- myeloid leukemia are not cured with cytarabine-based chemotherapy: Results from
mic granulocytic sarcoma treated with chemotherapy with or without radiotherapy. Cancer and Leukemia Group B 8461. Clin Cancer Res 4:1235, 1998.
Leukemia 17:1100, 2003. 290. Melnick A, Licht J: Deconstructing a disease, RARalpha, its fusion partners, and their
261. Yamauchi K, Yasuda M: Comparison of nonleukenic granulocytic sarcoma. Cancer 94: roles in the pathogenesis of acute promyelocytic leukemia. Blood 93:3167, 1999.
1739, 2002. 291. LoCoco F, Diverio D, Falini B, et al: Genetic diagnosis and molecular monitoring in
262. Tsimberidou AM, Kantarjian HM, Wen S, et al: Myeloid sarcoma is associated with the management of acute promyelocytic leukemia. Blood 94:12, 1999.
superior event-free survival and overall survival compared with acute myeloid leuke- 292. Poirel H, Rack K, Dalbesse E, et al: Incidence and characterization of MLL gene
mia. Cancer 113:1370, 2008. (11q23) rearrangements in acute myeloid leukemia M1 and M5. Blood 87:2496, 1996.
263. Byrd JC, Weiss RB, Arthur DC, et al: Extramedullary leukemia adversely affects 293. Schoch C, Schnittger S, Klaus M, et al: AML with 11q23/MLL abnormalities as
hematologic complete remission rate and overall survival in patients with t(8;21) defined by the WHO classification: Incidence, partner chromosomes, FAB subtype,
(q22;q22): Results from Cancer and Leukemia Group B 8461. J Clin Oncol 15:466, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically
1997. analyzed AML cases. Blood 102:2395, 2003.

Kaushansky_chapter 88_p1373-1436.indd 1419 9/21/15 11:02 AM